Overview

HER2 Vaccine for Locally Advanced Breast Cancer

Status:
RECRUITING
Trial end date:
2030-03-01
Target enrollment:
Participant gender:
Summary
The goal of this study is to test an investigational vaccine to activate the immune system to fight breast cancer.
Phase:
PHASE1
Details
Lead Sponsor:
Pravin T.P Kaumaya
Treatments:
CHP-HER2 vaccine